De novo peptide design with C3a receptor agonist and antagonist activities: Theoretical predictions and experimental validation

导出原文传递

翻译打印收藏纠错

作者： Bellows-Peterson, M.L. ^[1] ; Fung, H.K. ^[2] ; Floudas, C.A. ^[3] ; Kieslich, C.A. ^[4] ; Zhang, L. ; Morikis, D. ; Wareham, K.J. ; Monk, P.N. ; Hawksworth, O.A. ; Woodruff, T.M.

作者单位： Department of Bioengineering, University of California at Riverside, Riverside, CA, United States ^[1] Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08544, United States ^[2] School of Biomedical Sciences, University of Queensland, Brisbane, Australia ^[3] Department of Infection and Immunity, University of Sheffield Medical School, Sheffield, United Kingdom ^[4]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of Medicinal Chemistry

2012年55卷9期

4159-4168页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

De novo peptide design with C3a receptor agonist and antagonist activities: Theoretical predictions and experimental validation

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

De novo peptide design with C3a receptor agonist and antagonist activities: Theoretical predictions and experimental validation

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

检索历史清除